Anteris Technologies Global (AVR) Gains from Sales and Divestitures (2025)
Anteris Technologies Global (AVR) reported Gains from Sales and Divestitures of $685847.0 for Q4 2025.
Anteris Technologies Global (AVR) Gains from Sales and Divestitures (2025) Analysis & Trends
Anteris Technologies Global (AVR) has 1 years of Gains from Sales and Divestitures data on file, last reported at $685847.0 in Q4 2025.
- Gains from Sales and Divestitures for Q4 2025 came in at $685847.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $685847.0 (changed N/A YoY), and the FY2025 annual result was $685847.0, changed N/A from the prior year.
- Gains from Sales and Divestitures held at $685847.0 in Q4 2025 per AVR's latest filing.
- Over five years, Gains from Sales and Divestitures peaked at $685847.0 in Q4 2025 and troughed at $685847.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Anteris Technologies Global | 779.46 Mn | 779.43 Mn | 380,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 685,847.00 |
| Dec 31, 2025 | 685,847.00 |